Pediatric Drugs

Paediatr Drugs

1174-5878

1179-2019

Therapeutic Area

Clinical Pharmacology, Pediatrics, Pharmacology, Vaccines/Vaccinology

Academics, Caregivers, Clinical Pharmacologists, Family Practice Physicians, General Practitioners, Neonatologists, Patients, Pediatricians, Perinatologists, Pharmacists, Pharmacologists, Primary Care Physicians

Pediatric Drugs promotes the optimization and advancement of all aspects of pharmacotherapy for healthcare professionals interested in pediatric drug therapy (including vaccines). The program of review and original research articles provides healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology and the care of children and adolescents. The Journal includes: - overviews of contentious or emerging issues. - comprehensive narrative reviews of topics relating to the effective and safe management of drug therapy through all stages of pediatric development. - practical reviews covering optimum drug management of specific clinical situations. - systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. - Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in the pediatric population. - original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies. Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Pediatric Drugs may be accompanied by plain language summaries to assist readers in understanding important medical advances. All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication. Pediatric Drugs promotes the optimization and advancement of all aspects of pharmacotherapy for healthcare professionals interested in pediatric drug therapy (including vaccines). The program of reviews and original research articles provides healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology and the care of children and adolescents, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of pediatric conditions; and the practical management of specific clinical situations. The journal Also offers the ability to create digital features as well as host them.

No associations affiliated with this journal

Adis, part of Springer Nature

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines